DBV Technologies (DBVT) Current Deferred Revenue (2015 - 2019)

DBV Technologies (DBVT) posted quarterly Current Deferred Revenue of $6.2 million for Q2 2019, up 25.46% on a QoQ basis from $5.0 million in Q4 2018.

DBV Technologies (DBVT) Current Deferred Revenue (2015 - 2019) Analysis & Trends

DBV Technologies (DBVT) has reported Current Deferred Revenue for 5 consecutive years, with $6.2 million the latest figure, recorded in Q2 2019.

  • Quarterly Current Deferred Revenue changed N/A year-over-year to $6.2 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $6.2 million (changed N/A YoY) and the FY2018 annual result came in at $5.0 million, up 23.26% from the prior year.
  • Current Deferred Revenue climbed to $6.2 million in Q2 2019 per DBVT's latest filing, from $5.0 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for DBVT reached as high as $6.2 million in Q2 2019 and fell as low as $1.1 million in Q4 2015.
  • A 5-year average of $4.2 million and a median of $4.7 million in 2016 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2016 — Current Deferred Revenue surged 310.62% — and 2017, when it decreased 14.13%.
  • Year by year, Current Deferred Revenue stood at $1.1 million in 2015, then jumped by 310.62% to $4.7 million in 2016, then fell by 14.13% to $4.0 million in 2017, then increased by 23.26% to $5.0 million in 2018, then gained by 25.46% to $6.2 million in 2019.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $6.2 million, $5.0 million, and $4.0 million for Q2 2019, Q4 2018, and Q4 2017 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 DBV Technologies 267.50 Mn 92.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 6.22 Mn
Dec 31, 2018 4.96 Mn
Dec 31, 2017 4.03 Mn
Dec 31, 2016 4.69 Mn
Dec 31, 2015 1.14 Mn